Subgingival Plaque as a Potential Reservoir for SARS-CoV-2 Virus in Patients Recovered from COVID-19 Infection: A Cross-sectional Study

ABSTRACT

Background: Subgingival plaque biofilm is a potential harboring site for bacteria and viruses, serving as a source of entry into the bloodstream. The presence of Severe Acute Respiratory Syndrome Coronavirus 2 RNA (SARS-CoV-2 RNA) in subgingival plaque could be a possible source for cross infection due to aerosol contamination during dental procedures. Objective: The objective of this study was to investigate the presence of SARS-CoV-2 RNA in the subgingival plaque biofilm of patients who recovered from COVID-19 infection. Methodology: Ten subjects visiting the Outpatient clinic with a previous history of COVID-19 infection were recruited for this cross-sectional study. Subgingival plaque sample was collected from all four quadrants using a sterile curette. Nasopharyngeal and oropharyngeal swabs were taken from all the subjects. Reverse transcriptase real-time qualitative polymerase chain reaction (RT-PCR) was used to determine the presence of SARS-CoV-2 RNA using BAG SARS-CoV-2 RT-PCR kit targeting E gene, RdRp gene, and internal control. Results: Ten participants (seven females and three males) with a previous history of COVID-19 infection were included in the study. Six participants previously presented with mild COVID-19 infection (uncomplicated upper respiratory tract infection, mild fever, cough, sore throat, nasal congestion, malaise, headache, without evidence of breathlessness or hypoxia), and four participants previously presented with moderate COVID-19 infection (dyspnea and or hypoxia, fever, cough, SpO2 90%−94% on room air, respiratory rate more or equal to 24 per minute) according to clinical management protocol for COVID-19, Government of India. The nasopharyngeal, oropharyngeal, and subgingival plaque samples tested negative for SARS-CoV-2 RNA. Conclusion: The absence of the SARS-CoV-2 virus in the subgingival plaque sample of patients recovered from COVID-19 infection suggests that dental plaque could not be a potential reservoir of the virus. However, clinicians should take at most precautions while treating the patients recovered from COVID-19 infection and should anticipate a change in subgingival environment leading to alteration in periodontal disease progression.

KEYWORDS

• Subgingival plaque
• SARS-CoV-2
• COVID-19 infection
• periodontal disease
• oral health

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.1177/0976500X231224526Copy

RELATED ARTICLES

Matched on volume, issue, section and article type within J Pharmacol. Pharmacother..

• Article · VOLUME 16, ISSUE 1Changing Pattern of Substance Abuse in Patients Attending a Regional Psychiatric Rehabilitation Center at Al-Qassim, Saudi ArabiaYasir A. Ibrahim, Shalam Mohamed Hussain, Ayesha Farhana Syeda, Ahmed Mohamed Farghly, Muhammed Hassan Nasr, Rana Salem Alsaadi, Khalid Abdullah A. Alharbi · pp. 102–112Original Research ArticleSame type: Article
• Article · VOLUME 17, ISSUE 1Curcuma xanthorrhiza Rhizome Extract Attenuates the Complete Freund’s Adjuvantinduced Rheumatoid Arthritis in RatsPatrick A. Kalona, Uma Sundaresan, Chellappandian M., Ariharasivakumar G. · pp. 101–110Original Research ArticleSame type: Article
• Article · VOLUME 16, ISSUE 1Evaluation of Awareness and Perception Regarding Conflict of Interest in Research Among the Postgraduate Students in a Tertiary Care CenterSnehalata Ghajbhiye, Raakhi Tripathi, Sharmila Jalgoankar, Antara Pohregaonkar, Sumit Ourasang · pp. 113–118Original Research ArticleSame type: Article
• Article · VOLUME 17, ISSUE 1Comparative Study of in vitro Anti-proliferative Activity of Metformin, Teneligliptin, and Canagliflozin against Breast Cancer Cell LineGowri Venugopal, Kumaravelu Punnagai, Sukumar Ramya · pp. 111–116Original Research ArticleSame type: Article